This targeted course covers the FDA’s new exemption of specific Class II clinical toxicology test systems from 510(k) premarket notification requirements, effective October 6, 2026. Learn which test systems are now exempt, the labeling and documentation standards required to maintain compliance, and how these regulatory changes affect your operations, especially for devices used in employment and insurance drug testing—including Federal programs. Understand the practical steps manufacturers must take to avoid costly penalties and maintain market access under the updated rule.
In this course you will learn the following:
* Understand the scope and intent of the FDA’s final rule on 510(k) exemptions for specified Class II clinical toxicology test systems.
* Identify which device types and uses are covered by the exemption and which remain subject to 510(k) requirements.
* Apply the general and partial limitations of exemption, including labeling requirements.
* Recognize ongoing regulatory obligations for exempt devices.
* Assess the consequences of non-compliance with the final rule and related FDA regulations.
